Table 1.
Demographic data and clinical characteristics of participating children and parents
| Characteristics | Participants | X2 between countries’1 |
Argentina | X2 within Argentinaa | Sweden | X2 within Swedena |
|---|---|---|---|---|---|---|
| Total number, n (%) | 58 | 30 (51.7) | 28 (48.3) | |||
| Gender distribution, n (%) | 0.451 | 0.201 | 0.851 | |||
| Female | 24 (41.4) | 11 (36.7) | 13 (46.4) | |||
| Male | 34 (58.6) | 19 (63.3) | 15 (53.6) | |||
| Age groups, mean (sd) | 8.67 (5.1) | 0.801 | 8.67(5.18) | 1.001 | 8.68 (5.16) | 1.001 |
| 2–4 years | 19 (32.8) | 10 (33.3) | 9 (32.1) | |||
| 5–7 years | 10 (17.2) | 4 (13.3) | 6 (21.4) | |||
| 8–12 years | 10 (17.2) | 6 (20.0) | 4 (14.3) | |||
| 13–18 years | 19 (32.8) | 10 (33.3) | 9 (32.1) | |||
| Diagnostic groups, n (%) | 0.111 | p < 0.0001 | 0.241 | |||
| I Leukaemia | 33 (56.9) | 21 (70.0) | p = 0.004 | 12 (42.9) | ||
| II Solid tumours | 17 (29.3) | 6 (20.0) | I-II | 11 (39.3) | ||
| III CNS tumours | 8(13.8) | 3 (10.0) | p < 0.001 I-III | 5 (17.9) | ||
| Treatment modality, n (%) | 0.121 | p < 0.0001 | 0.351 | |||
| I Chemotherapy | 42 (72.4) | 25 (83.3) | p < 0.0001 I-II | 17 (60.7) | ||
| II Combined therapy | 16 (27.6) | 5 (16.7) | 11 (39.3) | |||
| Time since diagnosis (months), mean (sd) | 10.7 (8.7) | 0.671 | 10.9 (8.1) | 10.5(9.5) | ||
| Completed questionnaires, n (%) | 0.771 | p < 0.0001 | p < 0.0001 | |||
| I Female (F) | 43 (74.1) | 23 (76.7) | p < 0.0001 I-II | 20 (71.4) | p < 0.0001 I-II | |
| II Male (M) | 10 (17.2) | 5 (16.7) | 5 (17.9) | |||
| Both parents | 4 (6.9) | 2 (6.7) | 2 (7.1) | |||
| Grandparent | 1 (1.7) | 0 | 1 (3.6) | |||
| Parents/Couples employment, n (%) | 116 | p < 0.0001 | 60 (51.7) | p < 0.0001 | 56 (48.3) | p = 0.045 |
| I Work tasks; post-secondary education | 41 (35.3) | 16 (26.7) | 25 (44.6) | p = 0.045 I-II (F) | ||
| p = 0.012 I-III (F) | ||||||
| II Work tasks; no post-secondary education | 39 (33.6) | 17 (28.3) | 22 (39.3) | |||
| III Unemployed | 32 (27.6) | p < 0.0001 I-III (F) | 24 (40.0) | p = 0.005 I-III (F) | 8 (14.3) | |
| p < 0.001 II-III (F) | ||||||
| p < 0.0001 I-II (F) | p = 0.048 II-III (M) | |||||
| Not stated | 4 (3.4) | 3(5.0) | 1(18) |
aTested for difference in proportions by %2 test or in cases of small numbers, Fisher’s exact test. Significant differences are highlighted in bold type, 1Non significant F female, M male